These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34051236)

  • 1. Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
    Singh RR; McNamara JW; Sadayappan S
    J Biol Chem; 2021 Jul; 297(1):100836. PubMed ID: 34051236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
    Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
    Gruen M; Gautel M
    J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
    Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
    J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation
    Schwäbe FV; Peter EK; Taft MH; Manstein DJ
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
    Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
    J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYBPC3-c.772G>A mutation results in haploinsufficiency and altered myosin cycling kinetics in a patient induced stem cell derived cardiomyocyte model of hypertrophic cardiomyopathy.
    Steczina S; Mohran S; Bailey LRJ; McMillen TS; Kooiker KB; Wood NB; Davis J; Previs MJ; Olivotto I; Pioner JM; Geeves MA; Poggesi C; Regnier M
    J Mol Cell Cardiol; 2024 Jun; 191():27-39. PubMed ID: 38648963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
    J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
    Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA
    Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Desai D; Song T; Singh RR; Baby A; McNamara J; Green L; Nabavizadeh P; Ericksen M; Bazrafshan S; Natesan S; Sadayappan S
    bioRxiv; 2024 May; ():. PubMed ID: 38853909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2.
    Kunst G; Kress KR; Gruen M; Uttenweiler D; Gautel M; Fink RH
    Circ Res; 2000 Jan 7-21; 86(1):51-8. PubMed ID: 10625305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cardiac myosin-binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner.
    Bunch TA; Kanassatega RS; Lepak VC; Colson BA
    J Biol Chem; 2019 Nov; 294(44):16228-16240. PubMed ID: 31519753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
    Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal extension in cardiac myosin-binding protein C regulates myofilament binding.
    Bunch TA; Lepak VC; Kanassatega RS; Colson BA
    J Mol Cell Cardiol; 2018 Dec; 125():140-148. PubMed ID: 30359561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin.
    McNamara JW; Singh RR; Sadayappan S
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11731-11736. PubMed ID: 31142654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
    Kraft T; Montag J
    Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck?
    Ratti J; Rostkova E; Gautel M; Pfuhl M
    J Biol Chem; 2011 Apr; 286(14):12650-8. PubMed ID: 21297165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.
    Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB
    J Mol Cell Cardiol; 2008 Aug; 45(2):209-16. PubMed ID: 18573260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.